Risks and limits of Abnehmspritze Labor

The so-called 'weight loss injection' (GLP-1 agonists like semaglutide) requires a prescription and medical supervision. Direct-to-consumer lab tests offered before or during use (e.g., genetic tests for tolerability or efficacy) are not scientifically validated. There is no evidence that such tests can predict weight loss outcomes or prevent side effects. Risks include misinterpretation, false reassurance, unnecessary costs, and potential delay of proper medical care. The evidence for these lab tests is purely marketing-based. Consumers should rely on medical advice and approved indications, not on questionable genetic tests.